HomeFile

File

ESC 2020 | New Drug Improves Functional Capacity in Hypertrophic Cardiomyopathy

In patients with hypertrophic cardiomyopathy, myosin inhibitor mavacamten plus optimal medical therapy improved hemodynamics, functional capacity, and...

ESC 2020 | Atrial Fibrillation and Rhythm Control: A Matter of Time?

Early rhythm control therapy in patients recently diagnosed with atrial fibrillation reduces the risk of cardiovascular events...

Can Aspirin Use Be Interrupted After Angioplasty?

Aspirin discontinuation 1 to 3 months after angioplasty with continued P2Y12 inhibitor therapy reduces the bleeding risk without...

3rd Generation Valves in Large and X-Large Annuli

In patients with large and extra-large annuli, transcatheter aortic valve replacement (TAVR) is safe and feasible with...

SOLACI Webinar | Cardiac Arrhythmias

Watch again our Webinar on "Cardiac Arrhythmias” on our Youtube account.  We are interested in your opinion. Please,...

Is the Paradigm for Bifurcation Lesions Changing Once More?

Four years ago, we published a summary of the SMART-STRATEGY Study saying that, with bifurcation lesions, “less...

Good Evolution of Bicuspid Valves with EVOLUTE or EVOLUTE PRO

Courtesy of Dr. Carlos Fava. TAVR has matured over time and has advanced onto low risk patients, but...

Webinar SOLACI | TAVI Expert Panel

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...